Improving Outcome of Very Preterm Infants Using Collaborative Quality Improvement

Sponsor
Children's Hospital of Fudan University (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT04531839
Collaborator
Shanghai Children's Medical Center (Other), Shanghai First Maternity and Infant Hospital Tongji University School of Medicine (Other), Xinhua Hospital, Shanghai Jiao Tong University School of Medicine (Other), Obstetrics & Gynecology Hospital of Fudan University (Other)
3,500
6
2
12
583.3
48.8

Study Details

Study Description

Brief Summary

A multicenter interventional study using evidence-based collaborative quality improvement to reduce mortality and major morbidities of very preterm infants in six neonatal centers in Shanghai

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Evidence-based collaborative quality improvement
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
3500 participants
Allocation:
Non-Randomized
Intervention Model:
Sequential Assignment
Masking:
None (Open Label)
Primary Purpose:
Health Services Research
Official Title:
Improving the Outcome of Very Preterm Infants Using Evidence-based Collaborative Quality Improvement: A Multi-center Prospective Study
Anticipated Study Start Date :
Oct 1, 2022
Anticipated Primary Completion Date :
Jun 30, 2023
Anticipated Study Completion Date :
Sep 30, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Intervention period

The 1.5-year period during which all six participating centers receive evidence-based collaborative quality improvement interventions including benchmarking, potential better practice list, PDSA implementation, and collaborative learning

Behavioral: Evidence-based collaborative quality improvement
Evidence-based collaborative quality improvement interventions including benchmarking, potential better practice list, PDSA implementation and collaborative learning

No Intervention: Baseline period

The 2-year period before the collaborative quality improvement intervention

Outcome Measures

Primary Outcome Measures

  1. Mortality or any major morbidity [During first NICU hospitalization (about 1-4 months)]

    It is a binary varibale (1/0). The variabel would be setted into "1",if death or with any of the following major morbidities: bronchopulmonary dysplasia, necrotizing stage II or above, retinopathy of prematurity stage III or above, intraventricular hemorrhage grade III or above or cystic periventricular leukomalacia and late-onset epsis

Secondary Outcome Measures

  1. Mortality [During the procedure (about 1-4 months)]

    It is a binary varibale (1/0). The variabel would be setted into "1",if patients dead during hospitalization or 28 days after discharge against medical advice

  2. Bronchopulmonary dysplasia [During first NICU hospitalization (about 1-4 months)]

    It is a binary varibale (1/0). The variabel would be setted into "1",if patients reveived respiratory support or oxygen at 36 weeks' corrected gestational age or on discharge

  3. Necrotizing enterocolitis [During first NICU hospitalization (about 1-4 months)]

    It is a binary varibale (1/0). The variabel would be setted into "1",if patients appeared with NEC stage II or above

  4. Severe brain injury [During first NICU hospitalization (about 1-4 months)]

    It is a binary varibale (1/0). The variabel would be setted into "1",if patients appeared with intraventricular hemorrhage grade III or above within 28 days after birth or cystic periventricular leukomalacia

  5. Retinopathy of prematurity [During first NICU hospitalization (about 1-4 months)]

    It is a binary varibale (1/0). The variabel would be setted into "1",if patients appeared with ROP stage III or above.

  6. Late-onset sepsis [During first NICU hospitalization (about 1-4 months)]

    It is a binary varibale (1/0). The variabel would be setted into "1",if patients appeared with culture-proven sepsis after 72 hours after birth

  7. Length of NICU stay [During first NICU hospitalization (about 1-4 months)]

    days for the first NICU hospitalization

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A to 120 Days
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. Infants born at >=24+0 weeks' gestation and <32+0 weeks' gestation;

  2. Admitted to the participating NICUs within 7 days after birth during study period

Exclusion Criteria:
  1. Infants with major congenital anomalies;

  2. Infants who transferred to non-participating hospitals within 24 hours after birth;

Contacts and Locations

Locations

Site City State Country Postal Code
1 Obstetrics and Gynecoloy Hospital of Fudan University Shanghai Shanghai China 200011
2 Children's Hospital of Shanghai Jiao Tong University Shanghai Shanghai China 200062
3 Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine Shanghai Shanghai China 200092
4 Shanghai First Maternity and Infant Hosipital Shanghai Shanghai China 200126
5 Shanghai Children's Medical Center Shanghai Shanghai China 200127
6 Children's Hospital of Fudan University Shanghai Shanghai China 201102

Sponsors and Collaborators

  • Children's Hospital of Fudan University
  • Shanghai Children's Medical Center
  • Shanghai First Maternity and Infant Hospital Tongji University School of Medicine
  • Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
  • Obstetrics & Gynecology Hospital of Fudan University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Children's Hospital of Fudan University
ClinicalTrials.gov Identifier:
NCT04531839
Other Study ID Numbers:
  • SH-EPIQ 20200826
First Posted:
Aug 31, 2020
Last Update Posted:
Mar 15, 2022
Last Verified:
Mar 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Children's Hospital of Fudan University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 15, 2022